Rare Disease Report

Funding for Rare Disease Research Often From Non-Profits

MARCH 03, 2013
rarediseasereport

 

Brian Bigger, PhD, leads the Stem Cell & Neurotherapies laboratory at the University of Manchester in Manchester U.K.  The lab uses a multidisciplinary approach to investigate stem cell and gene therapies for neurological diseases, including Mucopolysaccharidosis (MPS) diseases such as MPS I (Hurler) and MPS IIIa (Sanfilippo). 

In this exclusive interview with Rare Disease Report, Dr. Bigger described how his lab obtains funding and how that research may lead to a better understanding of not just rare diseases but also more common conditions. For more information about Dr. Bigger’s research, visit  http://www.human-development.manchester.ac.uk/staff/BrianBigger/

Funding sources for Dr. Bigger’s lab include:

UK Society for Mucopolysaccharide Diseases (and their fundraising initiative Wicked Genes) 

Sanfilippo Children’s Research Foundation 

Jonah’s Just Begun 

Canadian Society for Mucopolysaccharide and Related Diseases 

National MPS Society 

 



Stay informed on the latest rare disease news and developments by signing up for our newsletter.
$related$
Copyright © RareDR 2013-2018 Rare Disease Communications. All Rights Reserved.